Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-17-002289

Options or other derivatives

  • President and CEO acquired 319,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hughes Thomas E. President and CEO 2017-01-27 Grant or award · Stock Option (Right to Buy) +319,000 319,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…